Ewen Cameron: The APA President Who Ran CIA Experiments

Subject

Donald Ewen Cameron, MD (1901-1967)

Institution

Allan Memorial Institute, McGill University, Montreal

Directorship

1943-1964

CIA funding

MKULTRA Subproject 68 via Human Ecology Fund, 1957-1964

Experimental protocol

Depatterning (induced coma + high-dose ECT) followed by psychic driving (audio-loop conditioning)

Civil resolution

Orlikow v. United States (1980-1988), $750,000 settlement; Canadian compensation program, 1992-1994

The Most Decorated Psychiatrist of His Generation

Donald Ewen Cameron was born in Bridge of Allan, Scotland, in 1901, trained in psychiatry at the University of Glasgow, and emigrated to North America in the late 1920s. By the end of his career he had been elected to lead the three most significant professional bodies in his discipline. The American Psychiatric Association made him its president in 1952. The Canadian Psychiatric Association followed in 1958. The World Psychiatric Association, founded in 1961, chose him as its inaugural president.

He had served on the Nuremberg trial commission that evaluated Rudolf Hess’s psychiatric state in 1945. He had directed the Allan Memorial Institute, a teaching hospital attached to McGill University, since 1943. He had built what was, by the mid-1950s, one of the most prominent psychiatric training programs in the English-speaking world. He had published extensively on schizophrenia, anxiety, and memory, and his lectures drew clinicians from across North America.

He had also begun, in the early 1950s, a program of experimental treatment whose methods he described in his own published papers with clinical confidence, whose patients emerged without the memories they had arrived with, and whose funding he had solicited from a private foundation that he would later learn was a CIA front. The gap between the public biography and the patient record is where the case file begins.

Subproject 68 and the Funding Chain

The CIA’s MKULTRA program, as scored in the prior pillar, operated through 149 subprojects between 1953 and 1973. Subproject 68 was authorized in 1957 to fund Ewen Cameron’s research at the Allan Memorial Institute. The contract was routed through the Society for the Investigation of Human Ecology, a Cornell-affiliated research organization whose funding Cameron was told came from private philanthropic sources.

The Human Ecology Fund, as the Society was renamed in 1961, was not what Cameron believed it to be. It had been established in 1955 by Harold Wolff, a Cornell neurologist and CIA contractor, with the specific operational purpose of channeling MKULTRA funds to principal investigators who would not have accepted direct CIA support. The arrangement is documented in the 1977 Senate Select Committee hearings and in Wolff’s own correspondence, which was among the materials preserved in the MKULTRA financial record.

Cameron’s grant proposals to the Human Ecology Fund described research objectives that aligned with his published clinical work: treatment of chronic schizophrenia and severe depression through experimental modification of established psychiatric practice. The specific experimental protocol he developed, which had no prior clinical validation and no informed-consent framework by any standard that would be recognized today, emerged from his own theoretical work on memory and personality rather than from the CIA’s interrogation-research priorities. The Agency’s interest was in the transferable knowledge about drug-assisted memory modification that Cameron’s research might produce. Cameron’s own interest was in the therapeutic ambition of reconstructing a patient’s personality from a cleared state.

The two interests overlapped in the protocol but did not require each other. Cameron would likely have conducted similar research without CIA funding; the CIA could have funded other principal investigators to pursue similar questions. What the funding relationship established is a specific chain of institutional responsibility that would later matter in federal court.

The Depatterning Protocol

Depatterning was Cameron’s term for the first phase of his experimental treatment. The patient was admitted to the Allan Memorial Institute’s “Sleep Room,” a converted ward in which patients were kept in continuous drug-induced coma using combinations of barbiturates, chlorpromazine, and other sedatives. Coma duration ranged from several days to, in the most documented cases, more than sixty consecutive days. Patients were awakened only for feeding and hygiene, and sometimes not for those.

During the coma period, patients received electroconvulsive therapy administered at the “Page-Russell” intensity: six seizures per treatment, multiple treatments per day, at two to three times the voltage standard of conventional clinical ECT. The conventional ECT protocol of the era produced one seizure per treatment, three treatments per week, for an acute depressive episode. Cameron’s patients received ECT doses that, by his own published figures, totaled between 30 and 150 times the conventional cumulative exposure.

The stated therapeutic rationale was that depatterning would erase the patient’s existing cognitive and behavioral patterns, creating what Cameron called a “state of minimal psychological function” from which the patient could be rebuilt through subsequent conditioning. The actual outcome, as documented in the patient records that survived, was durable retrograde amnesia extending years into the patient’s pre-treatment history, loss of procedural memory for learned adult skills, and in many cases the loss of continence and self-care capacities that would require months or years to partially recover.

Psychic Driving

The second phase of the protocol, which Cameron called “psychic driving,” was the intervention he believed would make depatterning therapeutic rather than merely destructive. After the patient emerged from the coma phase, headphones were placed on them and short recorded messages were played on continuous loop. The messages were either “positive drives” (therapeutic affirmations about the patient’s capacity for change and health) or “negative drives” (statements about the patient’s neurotic patterns, delivered in the voice of the treating psychiatrist).

Loop durations were extreme. Cameron’s published papers describe patients subjected to twenty-hour continuous listening sessions for periods of up to sixteen days. The theoretical basis was that the post-depatterning state left the patient maximally receptive to suggestion, and that continuous repetition would implant new cognitive patterns that the patient could not refuse because the patterns were imposed during a neurologically altered state.

The method produced no documented clinical improvement. It did produce, in many patients, specific auditory associations with distress that persisted for years after treatment ended. The surviving patient testimony, collected during the Orlikow civil action, includes accounts of patients who could not tolerate music or radio for the remainder of their lives because the sensory conditioning had been too thorough.

Orlikow and the Federal Court Record

Velma Orlikow was a Canadian woman who had been admitted to the Allan Memorial Institute in 1956 for treatment of depression following the birth of her daughter. She underwent Cameron’s protocol and emerged with severe and permanent memory impairment. Her husband, David Orlikow, later elected to the Canadian House of Commons, began in the late 1970s to press for an explanation of what had happened to his wife. The 1977 declassification of the MKULTRA financial record provided the explanation he had been seeking.

Orlikow and eight other former Allan Memorial patients filed suit in the United States District Court for the District of Columbia in 1980. The defendants were the United States, the Central Intelligence Agency, and Sidney Gottlieb personally. The legal theory was that the CIA’s funding of Cameron’s research, combined with the Agency’s knowledge that Cameron was conducting experimental treatment on patients who had not been informed of the experimental character of their care, constituted negligent supervision of a federally funded medical research program.

The case proceeded through eight years of procedural motions, discovery battles, and preliminary rulings. The CIA consistently argued that Cameron had operated independently and that the Agency bore no responsibility for treatment decisions made by a foreign national operating in a foreign jurisdiction. The plaintiffs argued that the funding relationship, the CIA’s knowledge of the protocol’s experimental status, and the deliberate concealment of the Agency’s role through the Human Ecology Fund established the necessary elements of supervisory negligence.

The settlement closed the American legal record. It did not close the Canadian one.

The Canadian Compensation Program

Canadian patients who had been treated at the Allan Memorial Institute but who were not among the Orlikow plaintiffs filed a class action in Canadian federal court in the early 1990s. The Canadian government, rather than proceed through adversarial litigation, established a compensation program in 1992 administered by the Department of Justice. The program paid $100,000 Canadian per eligible patient.

Eligibility was limited to patients who met specific criteria. The program required documented admission to the Allan Memorial Institute during the years Cameron’s protocol was active, documented treatment with depatterning or psychic driving as recorded in the Institute’s clinical records, and specific categories of documented outcome harm. Patients whose records had been lost, whose treatment had been intermediate between Cameron’s protocol and conventional psychiatric care, or who had died before the program’s establishment were largely excluded.

The program paid approximately 80 patients. Canadian researchers who have studied the record estimate that the total number of Allan Memorial Institute patients exposed to Cameron’s methods between 1943 and 1964 may have been between 300 and 1,000, depending on which inclusion criteria are applied. The difference between the compensated population and the exposed population is one of the open questions in the case.

• 1943

  Cameron becomes director of the Allan Memorial Institute at McGill University.

• 1950-1956

  Cameron develops and begins practicing depatterning and psychic driving protocols on patients admitted for conventional psychiatric treatment.

• 1952

  Cameron elected president of the American Psychiatric Association.

• 1957

  MKULTRA Subproject 68 begins funding Cameron's research via the Human Ecology Fund.

• 1961

  Cameron becomes founding president of the World Psychiatric Association.

• 1964

  Cameron retires from Allan Memorial Institute. CIA funding ends. MKSEARCH succeeds MKULTRA as the umbrella program.

• 1967

  Cameron dies of a heart attack while hiking in the Adirondacks, aged 66. He never discussed the CIA funding relationship publicly.

• 1977

  Senate Select Committee declassifies MKULTRA financial record. Cameron's funding relationship becomes public for the first time.

• 1980

  Orlikow v. United States filed in U.S. District Court for the District of Columbia.

• October 1988

  Orlikow settles for $750,000 across nine plaintiffs. CIA acknowledges funding without admitting liability.

• 1992-1994

  Canadian government compensation program pays $100,000 CAD to approximately 80 surviving patients.

• 2019

  A second Canadian class action, Tanny v. Attorney General of Canada, filed in Quebec Superior Court on behalf of patients excluded from the 1992 program. Proceedings ongoing.

What the Record Does Not Settle

Three specific questions remain active in the case file. Each one has current investigative or legal pressure, and each one could move from P3 to P2 as additional records become available.

The first is the count of exposed patients. The Allan Memorial Institute’s clinical records from Cameron’s directorship are partially held by McGill University, partially by the Canadian government, and partially by families of former patients who obtained records during the Orlikow and Tanny proceedings. No complete inventory has been produced. The difference between the compensated population (~80) and the estimated exposed population (300-1,000) represents a substantial pool of patient-harm outcomes for which neither civil nor compensatory resolution has been achieved.

The second is the medical-professional accountability question. Cameron held leadership positions in the American, Canadian, and World Psychiatric Associations during the years he was conducting the protocol. His professional colleagues included the leading figures of mid-century American psychiatry. No peer-review process, no ethical review board, and no institutional challenge interrupted his work between 1950 and 1964. The specific mechanism by which the field’s leading institutions tolerated the research is a subject that clinical psychiatric history has largely not engaged with directly. The Tanny plaintiffs’ filings cite this gap as a component of the continuing harm, and some clinical historians have argued that the field’s reluctance to address Cameron constitutes an unresolved professional accountability question.

The third is the operational-use question, which is the one where pattern inference most frequently outruns the evidence. Claims that Cameron’s methods produced operationally transferable knowledge used in CIA interrogation programs, in Vietnam-era Phoenix Program interrogation protocols, or in post-2001 enhanced interrogation techniques are widely asserted in MKULTRA coverage. The actual documentary evidence for specific transfer is thin. Sidney Gottlieb testified in 1977 that the research had produced “nothing of operational value.” Contemporary historians who have reviewed the transfer claims (John Marks, H.P. Albarelli Jr., Alfred McCoy) have concluded that the operational-use claim sits at P3-P4: plausible, sometimes specific, but not supported by documentary evidence of direct method transfer.

The Clinical Aftermath

The Allan Memorial Institute continues to operate as part of McGill University’s clinical infrastructure. Its current patient population receives conventional psychiatric care and has no connection to the experimental work of the 1950s and 1960s. The Sleep Room was decommissioned in 1965. McGill’s official institutional history acknowledges Cameron’s tenure and the controversy without engaging with the specifics of the patient harm record.

The clinical descendants of Cameron’s work, to the extent they can be identified, have been primarily cautionary. The ethical frameworks that govern contemporary psychiatric research, including informed consent requirements, institutional review board oversight, and the specific prohibitions against coma-based experimental intervention, took their modern form in the decade following the 1977 MKULTRA disclosures. The Nuremberg Code (1947) had existed throughout Cameron’s tenure but had been applied almost exclusively to German medical conduct rather than to American or Canadian research practice; the Helsinki Declaration (1964) was formalized while Cameron was still at Allan Memorial and did not prevent the final year of his protocol.

Further reading in this cluster

• MKULTRA Subproject by Subproject — the parent pillar covering the full 149-subproject record and the 1977 declassification
• The Reid Technique: How Interrogation Breaks the Innocent — the post-MKULTRA American interrogation methodology
• Strategic Use of Evidence (SUE) — the evidence-based alternative developed at the University of Gothenburg
• Cognitive Interview Technique — the Fisher and Geiselman witness-interviewing method
• McMartin Preschool Case — the satanic panic case that illustrates related harm through suggestive interview techniques
• MHEES Methodology — the evidence classification framework used throughout this cluster